The Synergistic Effects of Low Dose Fluorouracil and TRAIL on TRAIL-Resistant Human Gastric Adenocarcinoma AGS Cells

Figure 4

DcR1, DcR2, DR4, and DR5 expression. (a) Western blotting of DcR1, DcR2, DR4, and DR5; (b) histogram of DcR1 expression; (c) histogram of DcR2 expression; (d) histogram of DR4 expression; and (e) histogram of DR5 expression. Control: AGS cells treated with saline; 5-Fu: AGS cells treated with 0.5 μg/mL 5-Fu; TRAIL: AGS cells treated with 2 μg/mL TRAIL; combined: AGS cells treated with 0.5 μg/mL 5-Fu and 2 μg/mL TRAIL. ^#𝑃<0.01 compared with control group. ^▲𝑃<0.05 compared with 5-Fu group. ^&𝑃<0.01 compared with control and 5-Fu groups.^†𝑃<0.05 compared with TRAIL group.

(a)  

(b)

(c)

(d)

(e)